ArticleFrontiers in oncology2024

Corrigendum: Targeting JUN, CEBPB and HDAC3: a novel strategy to overcome drug resistance in hypoxic glioblastoma.

Yixing Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.